Xanthelasma Linked to Higher Cardiovascular Risks

New research shows that individuals with yellow eyelid plaques face a significantly increased chance of heart issues.

Updated on Sept. 19, 2026 in Heart Disease

Gouache-painted illustration of a stylized heart artery cross-section with subtle geometric ripples, symbolizing a clinical health indicator.
A new observational study indicates that patients with xanthelasma, or yellow eyelid deposits, have two to three times the risk of experiencing cardiovascular events. AI Illustration. Upload story photo >

Live Poll

Do you prioritize medical checkups when you notice unexplained physical changes on your body?

A large-scale observational study published in the journal Atherosclerosis reveals that people with xanthelasma face a two- to three-times higher risk of experiencing a cardiovascular event. The findings suggest these common yellow eyelid deposits serve as a persistent indicator of underlying heart health risks.

Why it matters

Identifying physical markers like xanthelasma can provide clinicians with a visual indicator of cardiovascular vulnerability in patients. This study emphasizes the importance of screening for heart-related complications in individuals who present with these specific lipid-rich deposits.

Researchers tracked 18,000 patients with xanthelasma against a control group of 18,000 people over a 10-year period. While cardiovascular event risks were significantly higher, the study found no difference in overall risk of death.

The players

Atherosclerosis

This is a peer-reviewed medical journal that publishes original research on the causes, pathology, and clinical consequences of vascular diseases.

The details

The observational study compared electronic medical records from 36,000 total participants to track the relationship between eyelid deposits and heart health. While the elevated risk of a cardiovascular event remained consistent throughout the decade-long follow-up, the study did not conclude that these deposits directly cause heart disease.

Timeline

  1. 10 years: Duration of follow-up observation used to track cardiovascular event risks.

Health Landscape

This study follows a pattern set by established clinical diagnostic protocols in its focus on leveraging visual dermatological markers to identify systemic disease risks. It marks an evolution in how external physical signs are used to forecast long-term cardiovascular health.

Patients who notice the development of xanthelasma should consult their primary care physician to discuss comprehensive cardiovascular screening. This visual indicator provides a clear opportunity for individuals to proactively manage heart health risks before acute events occur.

The takeaway

Visible eyelid deposits often correlate with significant underlying health conditions that require clinical attention. Monitoring for these markers can serve as an effective, non-invasive tool for early cardiovascular risk assessment.

Further reading

Learn more about risk factors and diagnostic developments in Heart Disease.

Source note: This article includes information reported by Prevention.

Live Poll

Do you prioritize medical checkups when you notice unexplained physical changes on your body?